 |
|
December 29, 2008 | |
CASE CCC IN THE NEWSUniversity Hospitals Case Medical Center Implements Non-Invasive Stool-Based DNA Screening for Colorectal Cancer NASA SPACE RADIATION SUMMER SCHOOLApplications are now being accepted for the 2009 NASA Space Radiation Summer School. Up to 15 students will be selected for the course to be held next summer at the Brookhaven National Laboratory (BNL) in Long Island, New York from May 27 – June 19, 2009. The goal of the course is to provide scientific and practical information to students and scientists who are either new to the NASA program or to charged particle radiobiology. At the completion of the summer school, students will have received the full complement of training required to conduct their own experiments at BNL. Course topics will include the physics and biochemistry of charged particle interaction with condensed matter, ionizing radiation dosimetry, DNA damage and repair, genotoxicity measurements, mechanisms of control and loss of cell cycle checkpoints and apoptosis, signal transduction including bystander effects, genomic instability, neurodegeneration, tissue remodeling and their relationships to carcinogenesis, and degenerative tissue risks including neurobiological damage by space radiation. Deadline: February 28 For details, please click here. MARK YOUR CALENDARS– Case CCC Basic Science Faculty Candidate PresentationsPlease mark your calendars for the following Faculty Candidate presentations: Candidate: Sang-Oh Yoon, PhD, Research Fellow, Department of Cell Biology, Harvard Medical School Chalk Talk: Candidate: Hugh P. Cam, PhD, Postdoctoral Fellow, Center for Cancer Research, NCI/NIH Chalk Talk: FUNDING OPPORTUNITY– AACR Stand Up To CancerThe AACR is pleased to announce a call for Letters of Intent for Stand Up To Cancer (SU2C) Innovative Research Grants. These grants, established in honor of the late Judah Folkman, MD, are open to independent investigators early in their careers and will fund novel, high-risk, high-reward cancer research proposals that have significant potential for translational application and hold great promise for advancing SU2C's overarching goal of improving and saving the lives of patients. Applicants must be tenure-track, independent investigators, who have completed their training no more than 7 years prior to the start of the grant term. That is, the applicant's first independent position must have started on or after August 2, 2002. Postdoctoral fellows, clinical research fellows, or any other researchers-in-training who are working under the direction of a scientific mentor are not eligible to apply. Proposals may focus on any discipline within basic, translational, or clinical research, provided that these criteria are met. LOI Deadline: January 22, 2009 For more information, please click here CANCER BIOLOGY COURSESEnrollment is currently open for the following Cancer Biology courses: David Danielpour, PhD will be teaching Basic Cancer Biology and the Interface with Clinical Oncology: PHRM 520/ PATH 520, a graduate-level introductory course in cancer biology taught through the Departments of Pharmacology and Pathology. This course will give students a broad overview of current basic cancer biology, highlight recent advances in cancer therapeutics, and provide a clinical perspective of the pathogenesis and treatment of common cancers. Drs. Danielpour and Joseph Bokar, MD, PhD will be teaching Clinical Interface to Cancer Biology Conference PHRM521/ PATH521, a conference-based enrichment course of PHRM 520/PATH520, taken concurrently with PHRM520/ PATH520 or the following Spring Semester. Details can be found at: MARK YOUR CALENDARS– Weekly Seminar Series on Applied Biostatistics in Clinical ResearchMark Schluchter, PhD will be teaching a weekly seminar series on Applied Biostatistics in Clinical Research, sponsored by W.T. Dahms Clinical Research Unit and the Cleveland Clinical and Translational Sciences Collaborative (CTSC). The seminars will run Mondays from 4:00 pm - 5:30 pm in School of Medicine E501, January 12– March 9, 2009. Online registration is open. To register and for more information, click here. For questions about the course, please contact Dr. Schluchter at mds11@case.edu. |
EVENTS**All events are open to anyone interested in attending December 29Pathology Research Seminar Series cancelled Hematology/Oncology Research In Progress Seminar cancelled December 30December 31Grand Rounds cancelled January 1Happy New Year! January 2Hematology/ Oncology Fellows Seminar cancelled Cancer Center Seminar Series/ Blood Club cancelled Taussig Cancer Institute Grand Rounds cancelled more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMSEmerging Trends in Cancer Immunotherapy Family-Centered Care Head and Neck Conference Ohio Collaborative Conference on Bioinformatics (OCCBIO) Annual Breast Cancer Update: Highlights of the National Meetings Case CCC Scientific Retreat 2009 **For more information on these symposiums, please contact Christine Rhoads. MARK YOUR CALENDARS– Cancer Center Scientific SeriesThe Case CCC is pleased to announce the Cancer Center Scientific Series, the first installment of which is scheduled for Thursday, January 8, 2009 from 4:00 pm - 6:00 pm in the Wolstein Research Building Auditorium, and will feature reports from the following Cancer Center Imaging Pilot Project awardees: Reception to follow. Everyone is welcome to attend. MARK YOUR CALENDARS– Case CCC Basic Science Faculty Candidate SeminarCase CCC Basic Science Faculty Candidate Hongwu Zheng, PhD will be giving a seminar on Monday, January 12, 2009 at 4:00 pm in Wolstein Research Building 1402. Dr. Zheng, a Post-Doc Research Fellow at the Dana Farber Cancer Institute/ Harvard Medical School, will be presenting Understanding Glioma Pathogenesis. All are encouraged to attend. |
CALL FOR PAPERS– Ohio Collaborative Conference on Bioinformatics (OCCBIO)The 4th Annual Ohio Collaborative Conference on Bioinformatics (OCCBIO 2009) will be held at CWRU June 15-17, 2009. The conference provides an interdisciplinary forum for the discussion of methods, research findings, and experiences in the area of Bioinformatics and Computational Biology. An important goal of the conference is to foster long-term collaborative relationships and networking opportunities within the domain of computational approaches to biology that benefit Ohio. OCCBIO invites researchers in the broad area of bioinformatics to submit their unpublished work to the conference. The conference proceedings will be indexed. Papers will be accepted December 27, 2008- January 27, 2009 For details, please click here. FUNDING OPPORTUNITY– James S. McDonnell FoundationThe Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas: Applications are continuously accepted for these awards. For more information, please click here. MARK YOUR CALENDARS– Molecular Targets for Cancer Prevention SymposiumFebruary 4-5, 2009 The Center for Cancer Research and the Division of Cancer Prevention at the National Cancer Institute are presenting Molecular Targets for Cancer Prevention Symposium on February 4-5, 2009 at the NIH Natcher Conference Center in Bethesda, Maryland. Evidence from both preclinical and clinical studies will provide an exciting forum for timely discussion and debate on the state-of-the-science, recent advances, and opportunities for discovery. Registration Deadline: January 11, 2009 For more information, please click here. MARK YOUR CALENDARS–2nd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen ScienceMarch 16–18, 2009 Human biospecimens are the foundation of the translational research that will transform patient care. The 2009 BRN Symposium: Advancing Cancer Research Through Biospecimen Science will focus on the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. This promises to be a stimulating and informative three-day event that will feature interactive discussions and presentations about biospecimen quality and recent advances in biospecimen science. Abstract Submission Deadline: February 9, 2009 For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESASCO Advanced Clinical Research Awards |
NIH Bulletin – Notices and Funding OpportunitiesNIH-Supported Centers for Population Health and Health Disparities (CPHHD) (P50)(RFA-CA-09-001) Pathophysiology of Bisphosphonates-associated Osteonecrosis of the Jaw (R01) (PA-07-132) Innovative and Applied Emerging Technologies in Biospecimen Science (R33)(RFA-CA-09-005) Application and Use of Transformative Emerging Technologies in Cancer Research (R21)(RFA-CA-09-006) Application and Use of Transformative Emerging Technologies in Cancer Research (R33)(RFA-CA-09-007) Innovative Technology Development for Cancer Research (R21) (RFA-CA-09-008) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Hassinger 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.hassinger@uhhospitals.org |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |